115 related articles for article (PubMed ID: 20205087)
1. [Glioblastoma multiforme--new hope due to modern therapeutical approaches].
Gautschi OP; Cadosch D; Collen TD; Land M; Hoederath P; Hildebrandt G; Fournier JY; Hundsberger T
Praxis (Bern 1994); 2010 Mar; 99(5):295-308. PubMed ID: 20205087
[TBL] [Abstract][Full Text] [Related]
2. [Temozolomide in patients with a glioblastoma multiforme: new developments].
Bromberg JE; Postma TJ
Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
[TBL] [Abstract][Full Text] [Related]
3. Distance to the neurooncological center: a negative prognostic factor in patients with glioblastoma multiforme. An epidemiological study.
Kerschbaumer J; Freyschlag CF; Bauer R; Obwegeser AA; Schubert GA; Thomé C; Seiz M
Anticancer Res; 2012 Dec; 32(12):5515-9. PubMed ID: 23225460
[TBL] [Abstract][Full Text] [Related]
4. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
6. Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide.
Beauchesne P
J Clin Oncol; 2002 Jul; 20(14):3180-1; author reply 3181. PubMed ID: 12118035
[No Abstract] [Full Text] [Related]
7. Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme.
De Sanctis V; Mazzarella G; Osti MF; Valeriani M; Alfó M; Salvati M; Banelli E; Tombolini V; Enrici RM
Anticancer Drugs; 2006 Sep; 17(8):969-75. PubMed ID: 16940807
[TBL] [Abstract][Full Text] [Related]
8. [Survival analysis following the addition of temozolomide to surgery and radiotherapy in patients with glioblastoma multiforme].
Gil-Salú JL; Román P; Benítez E; Maestro E; Pérez-Requena J; López-Escobar M
Neurocirugia (Astur); 2004 Apr; 15(2):144-50. PubMed ID: 15159792
[TBL] [Abstract][Full Text] [Related]
9. Treatment of glioblastoma multiforme with radiotherapy and concomitant and adjuvant temozolomide: translation of randomised controlled trial evidence into routine clinical practice.
Herbert C; Williams M; Sawyer H; Greenslade M; Cornes P; Hopkins K
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):372-3. PubMed ID: 21310598
[No Abstract] [Full Text] [Related]
10. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.
Panet-Raymond V; Souhami L; Roberge D; Kavan P; Shakibnia L; Muanza T; Lambert C; Leblanc R; Del Maestro R; Guiot MC; Shenouda G
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):473-8. PubMed ID: 18554821
[TBL] [Abstract][Full Text] [Related]
11. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ
Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615
[TBL] [Abstract][Full Text] [Related]
12. Prolonged survival of a patient with cervical intramedullary glioblastoma multiforme treated with total resection, radiation therapy, and temozolomide.
Tseng HM; Kuo LT; Lien HC; Liu KL; Liu MT; Huang CY
Anticancer Drugs; 2010 Nov; 21(10):963-7. PubMed ID: 20838208
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
[TBL] [Abstract][Full Text] [Related]
14. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ;
Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895
[TBL] [Abstract][Full Text] [Related]
15. Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients.
Combs SE; Wagner J; Bischof M; Welzel T; Wagner F; Debus J; Schulz-Ertner D
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):987-92. PubMed ID: 17967509
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study.
Combs SE; Gutwein S; Schulz-Ertner D; van Kampen M; Thilmann C; Edler L; Wannenmacher MM; Debus J
Strahlenther Onkol; 2005 Jun; 181(6):372-7. PubMed ID: 15925979
[TBL] [Abstract][Full Text] [Related]
17. Reoxygenation of glioblastoma multiforme treated with fractionated radiotherapy concomitant with temozolomide: changes defined by 18F-fluoromisonidazole positron emission tomography: two case reports.
Narita T; Aoyama H; Hirata K; Onodera S; Shiga T; Kobayashi H; Murata J; Terasaka S; Tanaka S; Houkin K
Jpn J Clin Oncol; 2012 Feb; 42(2):120-3. PubMed ID: 22198964
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
Athanassiou H; Synodinou M; Maragoudakis E; Paraskevaidis M; Verigos C; Misailidou D; Antonadou D; Saris G; Beroukas K; Karageorgis P
J Clin Oncol; 2005 Apr; 23(10):2372-7. PubMed ID: 15800329
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors other than the performance status and age for glioblastoma multiforme: a single-institution experience.
Caloglu M; Yurut-Caloglu V; Karagol H; Bayir-Angin G; Turan FN; Uzal C
J BUON; 2009; 14(2):211-8. PubMed ID: 19650168
[TBL] [Abstract][Full Text] [Related]
20. Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme.
Roa W; Xing JZ; Small C; Kortmann R; Miriamanoff R; Okunieff P; Shibamoto Y; Jeremic B
Expert Rev Anticancer Ther; 2009 Nov; 9(11):1643-50. PubMed ID: 19895247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]